Meral Kayikcioglu/
Dec 3, 2025, 02:29
Meral Kayikcioglu: Successfully Completing FDA Inspections for Two Phase 3 Trials
Meral Kayikcioglu, Professor of Cardiology at Ege University and Director of the Lipid and Prevention Clinic, shared on LinkedIn:
“We successfully completed FDA inspections for two different Phase 3 RCTs (LIB-HoFH and HeFH)! This extremely challenging and prestigious inspection in pharmaceutical R&D processes also demonstrated our compliance with global standards.
To my knowledge, only 10 FDA inspections have been conducted in our country to date. Successfully passing one of these inspections is a source of great pride for both our team and our country. I thank all my teammates and stakeholders who contributed to this process.
We continue to work for stronger, more innovative, and more reliable science!”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis